![Susan Wyrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Wyrick
Comptroller/Controller/Revisor på
SANA BIOTECHNOLOGY, INC.
Förmögenhet: 614 093 $ per 2026-07-31
Profil
Ms. Susan D.
Wyrick, CPA, is a Senior Vice President-Finance & Accounting at Sana Biotechnology, Inc. Ms. Wyrick was previously employed as a Vice President & Controller by Juno Therapeutics, Inc. and a Chief Accounting Officer & Vice President-Finance by OncoGenex Pharmaceuticals, Inc. She received her undergraduate degree from the University of Washington.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC. 0,08 % | 2026-03-09 | 196 196 ( 0,08 % ) | 614 093 $ | 2026-07-31 |
Aktiva positioner av Susan Wyrick
| Företag | Position | Start |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Comptroller/Controller/Revisor | 2024-10-04 |
Tidigare kända positioner av Susan Wyrick
| Företag | Position | Slut |
|---|---|---|
| JUNO THERAPEUTICS INC | Comptroller/Controller/Revisor | 2018-10-01 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Comptroller/Controller/Revisor | 2014-06-11 |
Susan Wyricks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
54
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
